LDN Social Media
Get connected with us on social networks
Digital Journal.com
AgelessRx Reports Promising Results from LDN Quality of Life Study for Healthy Aging
PRESS RELEASE
Published August 30, 2024
Ann Arbor, MI - AgelessRx, a leading online telehealth platform specializing in longevity science, is proud to announce promising results from their recent study on Low Dose Naltrexone (LDN) for Quality of Life (QoL) improvement in healthy aging. The study, conducted in collaboration with esteemed researchers and published in the prestigious Aging Cell journal, underscores the potential of LDN as a promising therapy in the field of longevity and healthy aging.
Low Dose Naltrexone (LDN) has been gaining attention in recent years for its potential benefits in treating a wide range of conditions, including autoimmune diseases, chronic pain, and certain mental health disorders. However, its role in promoting healthy aging and improving the quality of life among older adults has been less explored until now. AgelessRx's study delves into this promising application, providing new insights into how LDN can be a critical component of longevity therapies.
The LDN Quality of Life study was designed to assess the impact of LDN on various aspects of well-being in older adults. The study included participants whom were administered low doses of Naltrexone over a period of time. The primary focus was on assessing improvements in physical health, cognitive function, emotional well-being, and overall vitality.
Continue reading here https://www.digitaljournal.com/pr/news/get-featured/agelessrx-reports-promising-results-ldn-1260154629.html